Last edition
News about
Illumina Launches Billion Cell Atlas to Power AI-Driven Drug Discovery
Illumina, Inc. has launched the Illumina Billion Cell Atlas, the world’s largest genome-wide genetic perturbation dataset, designed to accelerate AI-enabled drug discovery across the pharmaceutical industry.
Innovation Led Growth Dominates Indian Pharma Market in 2025
The India’s pharmaceutical market grew 10.6 percent year-on-year in December 2025, driven by chronic therapies, GLP-1 drugs, and strong innovation-led demand.
Eisai, Nuvation Bio Collaborates to Expand Taletrectinib's Global Reach
The collaboration between Eisai and Nuvation to expand global development and commercialisation of taletrectinib for ROS1-positive non-small cell lung cancer.
Genethon Partners with AskBio on Pompe Gene Therapy
The licensing deal enables AskBio to advance the clinical development of Genethon’s investigational gene therapy for Pompe disease through an industry partnership.
J&J's Tecvayli Cuts Death Risk in Phase III Multiple Myeloma Study
Phase III MajesTEC-9 shows Tecvayli significantly improves survival, reducing progression or death risk by 71 percent versus standard care in relapsed multiple myeloma.
Amneal Unveils New Brand to Expand Access to Medicines
The refreshed brand features a new visual identity and “Signature” logo that reflects trust in healthcare, patient impact, and Amneal’s focus on expanding access to medicines across complex therapeutic areas.
Dr Reddy's Launches First-to-Market Olopatadine Ophthalmic Solution in US
With the US launch of its first-to-market OTC Olopatadine 0.7 percent eye drops, Dr Reddy’s expands access to allergy relief for itchy eyes caused by pollen and other common allergens.
Tjoapack strengthens bottle packaging capabilities at Netherlands facility
Tjoapack, a global contract packaging organization serving the pharmaceutical industry, has expanded its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur facility in the Netherlands with the installation of a second production line.
Sanofi Warns of Near-Term Weakness in US Vaccine Demand Amid Antivax Rhetoric
French pharmaceutical company Sanofi expects near-term weakness in vaccine sales in the United States, attributing the anticipated softness to growing scepticism around immunizations that the company says has been fueled by misinformation.
US and European Regulators Set Principles for Responsible AI Use in Drug Development
US and European medicines regulators have jointly issued a set of guiding principles to support the safe, effective and responsible use of artificial intelligence (AI) in drug development, marking a significant step toward regulatory alignment on emerging technologies.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy